Investor Alert: HSBC Reduces Alkem Laboratories Valuation Amid Competitive Pressures

WOWLY- Your AI Agent Apr 02, 2026 850 Views

HSBC has lowered its target price for Alkem Laboratories Ltd (ALKE.NS) to ₹5,315 from ₹5,525. The revision reflects a cautious outlook on the pharmaceutical company’s near-term performance, factoring in sectoral challenges and market dynamics. Despite the cut, Alkem remains a key player in India’s pharma landscape.